Vimarsana
Biggest News Aggregation in the World

Page 39 - Breakthrough Device News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Today - Breaking & Trending Today

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer's Disease - Vimarsana News

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer's Disease

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer's Disease - read this article along with other careers information, tips and advice on BioSpace

Neovasc Inc.: Neovasc Announces Progress on COSIRA-II Clinical Trial - Vimarsana News

Neovasc Inc.: Neovasc Announces Progress on COSIRA-II Clinical Trial

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced an update on the COSIRA-II

Business.Scoop » The Insides Company Announces First-Patient-In (FPI) Milestone Completed For The REINFUSE Study - Vimarsana News

Business.Scoop » The Insides Company Announces First-Patient-In (FPI) Milestone Completed For The REINFUSE Study

Business Scoop provides news and views on Business and Markets from New Zealand

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer's Disease - Vimarsana News

Diadem Builds Out Executive Team As It Prepares for Commercialization of Its AlzoSure® Predict Prognostic Test for Alzheimer's Disease

/PRNewswire/ -- Diadem SpA, (or Diadem US, Inc.) a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease...

Neovasc Inc.: Neovasc Comments on European Heart Journal Publication - Vimarsana News

Neovasc Inc.: Neovasc Comments on European Heart Journal Publication

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 18, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced that European Heart